The clinical significance of pre-operative serum CA 125 in ovarian cancer
- 1 July 1987
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 94 (7) , 692-695
- https://doi.org/10.1111/j.1471-0528.1987.tb03177.x
Abstract
In a prospective study of 52 patients with ovarian malignancy followed up for 3–18 months the clinical significance of pre‐operative serum CA 125 as a tumour marker was assessed. In 41 patients with epithelial ovarian cancer, the level of CA 125 correlated well with tumour load as indicated by FIGO stage. All epithelial histological types, including mucinous. released CA 125 although serous and undifferentiated tumours produced quantitatively more antigen. There was, however, no correlation between CA 125 concentration and histopathological grade, nor did CA 125 level appear to be of any prognostic value in epithelial ovarian cancer. Elevated CA 125 levels were also found in patients with sex cord/stromal tumours, Krukenberg tumours, an ovarian sarcoma and a serous carcinoma of low malignant potential.This publication has 13 references indexed in Scilit:
- The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexesBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)American Journal of Obstetrics and Gynecology, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasmaAmerican Journal of Obstetrics and Gynecology, 1978
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Carcinoembryonic Antigen in Cancer of the Female Reproductive System Sequential Levels and Effects of Treatment*Australian and New Zealand Journal of Obstetrics and Gynaecology, 1973